Sandbox drug template: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) No edit summary |
Rim Halaby (talk | contribs) No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 4: | Line 4: | ||
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | YYYYY<sup>®</sup> FDA Package Insert | ! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | YYYYY<sup>®</sup> FDA Package Insert | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Lopressor black box warning|{{fontcolor|#FF0000|Black Box Warning}}]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ZZZZZ dosage and administration|Dosage and Administration]] | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ZZZZZ dosage and administration|Dosage and Administration]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ZZZZZ dosage forms and strengths|Dosage Forms and Strengths]] | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ZZZZZ dosage forms and strengths|Dosage Forms and Strengths]] | ||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ZZZZZ indications and usage|Indications and Usage]] | |||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ZZZZZ contraindications|Contraindications]] | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ZZZZZ contraindications|Contraindications]] | ||
| Line 23: | Line 25: | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ZZZZZ description|Description]] | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ZZZZZ description|Description]] | ||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ZZZZZ mechanism of action|Mechanism of Action]] | |||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ZZZZZ clinical pharmacology|Clinical Pharmacology]] | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ZZZZZ clinical pharmacology|Clinical Pharmacology]] | ||
| Line 36: | Line 40: | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ZZZZZ labels and packages|Labels and Packages]] | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ZZZZZ labels and packages|Labels and Packages]] | ||
|- | |- | ||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ZZZZZ pill images|Pill Images]] | ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ZZZZZ pill images and characteristics|Pill Images]] | ||
|- | |||
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ZZZZZ price|Price]] | |||
|- | |- | ||
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | [[XXXXX (patient information)|{{fontcolor|#2B3B44|Patient Information}}]] | ! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | [[XXXXX (patient information)|{{fontcolor|#2B3B44|Patient Information}}]] | ||